clindaseptin 25 mg/ml oral opløsning
chanelle pharmaceuticals manufacturing limited - clindamycinhydrochlorid - oral opløsning - 25 mg/ml
epityl 60 mg tabletter
chanelle pharmaceuticals manufacturing limited - phenobarbital - tabletter - 60 mg
exitel plus 150 mg+144 mg+50 mg tabletter
chanelle pharmaceuticals manufacturing limited - febantel, praziquantel, pyrantel - tabletter - 150 mg+144 mg+50 mg
prazitel forte vet. 175+504+525 mg tabletter
chanelle pharmaceuticals manufacturing limited - febantel, praziquantel, pyrantelembonat - tabletter - 175+504+525 mg
prazitel plus 150+144+50 mg tabletter
chanelle pharmaceuticals manufacturing limited - febantel, praziquantel, pyrantelembonat - tabletter - 150+144+50 mg
equicam 15 mg/ml oral suspension
chanelle pharmaceuticals manufacturing limited - meloxicam - oral suspension - 15 mg/ml - hest
milbetab 12,5+125 mg tabletter
chanelle pharmaceuticals manufacturing limited - milbemycinoxim, praziquantel - tabletter - 12,5+125 mg
milipraz 12,5+125 mg tabletter
chanelle pharmaceuticals manufacturing limited - milbemycinoxim, praziquantel - tabletter - 12,5+125 mg
zomarist
novartis europharm limited - vildagliptin, metformin-hydrochlorid - diabetes mellitus, type 2 - narkotika anvendt i diabetes - zomarist is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus:in patients who are inadequately controlled with metformin hydrochloride alone. in patients who are already being treated with the combination of vildagliptin and metformin hydrochloride, as separate tablets. in combination with other medicinal products for the treatment of diabetes, including insulin, when these do not provide adequate.
eucreas
novartis europharm limited - vildagliptin, metformin-hydrochlorid - diabetes mellitus, type 2 - drugs used in diabetes, combinations of oral blood glucose lowering drugs - eucreas is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus:in patients who are inadequately controlled with metformin hydrochloride alone. in patients who are already being treated with the combination of vildagliptin and metformin hydrochloride, as separate tablets. in combination with other medicinal products for the treatment of diabetes, including insulin, when these do not provide adequate glycaemic control.